About Nanordica Medical
Nanordica Medical is a company based in Tallinn (Estonia) founded in 2019 by Taavi Lipstok, Grigory Vasiliev, and Olesja Bondarenko.. Nanordica Medical has raised $2.3 million across 4 funding rounds from investors including European Union, Specialist and Superangel. The company has 12 employees as of September 30, 2024. Nanordica Medical offers products and services including Advanced Antibacterial Wound Dressing. Nanordica Medical operates in a competitive market with competitors including Adocia, Imbed Biosciences, Cresilon, Kane Biotech and Alafair Biosciences, among others.
- Headquarter Tallinn, Estonia
- Employees 12 as on 30 Sep, 2024
- Founders Taavi Lipstok, Grigory Vasiliev, Olesja Bondarenko
-
Sectors
TechnologyHealthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Nanordica Medical Oü
-
Annual Revenue
$3.12 K (USD)0as on Dec 31, 2023
-
Net Profit
$132.58 K (USD)210as on Dec 31, 2023
-
EBITDA
-
Total Equity Funding
$2.3 M (USD)
in 4 rounds
-
Latest Funding Round
$1.9 M (USD), Seed
May 16, 2024
-
Investors
European Union
& 6 more
-
Employee Count
12
as on Sep 30, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Nanordica Medical
Nanordica Medical offers a comprehensive portfolio of products and services, including Advanced Antibacterial Wound Dressing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Prevents infection and promotes healing in chronic wounds.
Funding Insights of Nanordica Medical
Nanordica Medical has successfully raised a total of $2.3M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.9 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Seed — $1.9M
-
First Round
First Round
(01 Jun 2022)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2024 | Amount | Seed - Nanordica Medical | Valuation | Specialist | |
| Feb, 2023 | Amount | Seed - Nanordica Medical | Valuation | Heidi Kakko , Erki Molder |
|
| Jun, 2022 | Amount | Grant - Nanordica Medical | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Nanordica Medical
Nanordica Medical has secured backing from 7 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include European Union, Specialist and Superangel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
B2B software, fintech, and tech companies are funded by Specialist.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused pre-seed and seed stage investments
|
Founded Year | Domain | Location | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Nanordica Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Nanordica Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Nanordica Medical Comparisons
Competitors of Nanordica Medical
Nanordica Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adocia, Imbed Biosciences, Cresilon, Kane Biotech and Alafair Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for diabetes and obesity treatment are developed.
|
|
| domain | founded_year | HQ Location |
Nanotech-based wound care products are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of hemostatic products for wound care
|
|
| domain | founded_year | HQ Location |
Therapeutic solutions for biofilm prevention and removal are developed.
|
|
| domain | founded_year | HQ Location |
Biomaterials and devices for internal wound healing are developed.
|
|
| domain | founded_year | HQ Location |
Dressing materials and medical devices
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Nanordica Medical
Frequently Asked Questions about Nanordica Medical
When was Nanordica Medical founded?
Nanordica Medical was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Where is Nanordica Medical located?
Nanordica Medical is headquartered in Tallinn, Estonia.
Is Nanordica Medical a funded company?
Nanordica Medical is a funded company, having raised a total of $2.3M across 4 funding rounds to date. The company's 1st funding round was a Grant of $79.77K, raised on Jun 01, 2022.
How many employees does Nanordica Medical have?
As of Sep 30, 2024, the latest employee count at Nanordica Medical is 12.
What is the annual revenue of Nanordica Medical?
Annual revenue of Nanordica Medical is $3.12K as on Dec 31, 2023.
What does Nanordica Medical do?
Nanordica Medical was founded in 2019 in Tallinn, Estonia, within the nanotechnology sector focused on healthcare. Antibacterial nanoparticles are developed for wound dressings to treat infected wounds, including diabetic foot ulcers, burns, surgical sites, deep traumatic injuries, and inflamed areas. Infection prevention is enabled, with capabilities for inactivating drug-resistant bacteria and incorporating reduced silver content. Operations center on product innovation for medical applications.
Who are the top competitors of Nanordica Medical?
Nanordica Medical's top competitors include Imbed Biosciences, Adocia and Cresilon.
What products or services does Nanordica Medical offer?
Nanordica Medical offers Advanced Antibacterial Wound Dressing.
Who are Nanordica Medical's investors?
Nanordica Medical has 7 investors. Key investors include European Union, Specialist, Superangel, Heidi Kakko, and Erki Molder.